Solis Agrosciences

Overview

Provides premium, highly specialized research capabilities to AgTech innovators
Offerings include greenhouse space, access to germplasm and raw materials, validating and running research, and molecular analysis tools
Rapidly tests and delivers new plant traits, launching with an end-to-end pipeline for gene-edited and transgenic plant generation & characterization
A continually expanding suite of service offerings are planned as Solis grows

Highlights

Recruited management team and established initial operations
Since a pilot launch in April 2022, Solis has secured many contracts from venture-backed ag biotech companies, demonstrating strong customer interest
Secured oversubscribed growth-capital financing
Acquired five-acre greenhouse business

Solis is proud to be a BioGenerator-built company. BioGenerator developed the concept for Solis, provided initial funding and has been a tremendous help in setting up our operations at the Helix Center. I am quite excited to continue working with the BioGenerator team as we build Solis into a world-class institution and a valuable addition to the St. Louis ecosystem.

Mary Fernandes
Co-founder & President, Solis Agrosciences | BioGenerator EIR

BioGenerator Contributions

Solis was conceived of by BioGenerator Ventures Senior Managing Director, Charlie Bolten, and EIR, Martha Schlicher
BioGenerator EIR, Mary Fernandes, is serving as President of Solis and is co-founder
BioGenerator EIRs, David Smoller and Martha Schlicher, are co-founders and serve key leadership or board roles
BioGenerator Ventures was the sole source of capital for the first ~year of operations
The company began operations from the BioGenerator Labs at 39N